Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 12, 2019 11:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies Announces Formation of Scientific and Medical Advisory Board; M. Patricia Rivera, MD, Joins Board as Chair

SAN ANTONIO, March 12, 2019 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced the formation of a Scientific and Medical Advisory (SMA) Board to provide...
March 06, 2019 11:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies Selected as Finalist for Cancer Innovation Award

SAN ANTONIO, March 06, 2019 (GLOBE NEWSWIRE) -- Healthcare innovators Lyfebulb and Helsinn selected bioAffinity Technologies, a privately held biotech company developing diagnostics and therapeutics...
October 23, 2018 11:00 ET | Source: bioAffinity Technologies, Inc.

South Texas Veterans Health Care System Joins Test Validation Trial of bioAffinity’s CyPath® Lung

SAN ANTONIO, Oct. 23, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced that the South Texas Veterans Health Care System (STVHCS), which is...
September 18, 2018 14:00 ET | Source: bioAffinity Technologies, Inc.

Mount Sinai Joins Test Validation Trial of bioAffinity’s CyPath® Lung

SAN ANTONIO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced that the Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY,...
July 31, 2018 11:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies Welcomes Mohsin Y. Meghji to Board of Directors

SAN ANTONIO, July 31, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biomedical company advancing breakthrough cancer diagnostics and therapeutics, is pleased to welcome Mohsin...
July 17, 2018 14:40 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies Opens Test Validation Trial of CyPath® Lung

SAN ANTONIO, July 17, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced it has commenced its test validation trial for CyPath® Lung, an...
January 05, 2018 09:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies to Present at Biotech Showcase™ Annual Conference

SAN ANTONIO, Texas, Jan. 05, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced that it will present its proprietary technology to detect...
November 29, 2017 11:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies Welcomes New Board Members

SAN ANTONIO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics and therapeutics company, today announced the appointments of Stephen Squinto, Ph.D., and...
July 19, 2017 15:00 ET | Source: bioAffinity Technologies, Inc.

bioAffinity Technologies Announces $4 Million Series A Funding

SAN ANTONIO, July 19, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held company advancing early-stage cancer diagnostics and precision therapeutics, announced today that it raised...
March 09, 2017 19:02 ET | Source: bioAffinity Technologies, Inc.

City of San Antonio Invests in bioAffinity Technologies

SAN ANTONIO, March 09, 2017 (GLOBE NEWSWIRE) -- The San Antonio City Council today authorized the San Antonio Economic Development Corporation (SAEDC) to invest in locally based bioAffinity...